In addition, many in vitro studies have shown that melatonin-rich residue particles can cause tumor growth by modulating cell signaling pathways, such as MEK/ERK and PI3K/Akt/mTOR pathways[36]. The gene discussed is AKT1; the disease is neoplasm.